Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks?

With a market cap of $155.7 billion, Boston Scientific Corporation (BSX) is a global medical device company operating through three segments: Cardiovascular, Rhythm and Neuro, and MedSurg. It offers technologies such as drug-eluting stents, implantable cardiac devices, and systems for gastrointestinal, urological, and neurological treatments.

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Boston Scientific fits this criterion perfectly. Boston Scientific has pursued both organic innovation and strategic acquisitions to build a comprehensive portfolio addressing complex diseases, including coronary artery disease, chronic pain, and cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.